%0 Journal Article
%T Phase 1 Parkinson¡¯s Disease Studies Show the Dopamine D1/D5 Agonist PF-06649751 is Safe and Well Tolerated
%A David L. Gray
%A Gang Feng
%A Kathleen Thayer
%A Sridhar Duvvuri
%A U. Shivraj Sohur
%A Yao Zhang
%J Archive of "Neurology and Therapy".
%D 2018
%R 10.1007/s40120-018-0114-z
%X The online version of this article (10.1007/s40120-018-0114-z) contains supplementary material, which is available to authorized users
%K Dopamine D1 receptor
%K Dopamine D5 receptor
%K Dopamine receptor agonists
%K Parkinson¡¯s disease
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283789/